Apoptosis, necroptosis and autophagy in colorectal cancer: Associations with tumor aggressiveness and p53 status.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 18 01 2019
revised: 05 04 2019
accepted: 26 04 2019
pubmed: 18 5 2019
medline: 15 1 2020
entrez: 18 5 2019
Statut: ppublish

Résumé

Cleaved caspase-3 (CC3), phosphorylated-mixed-lineage kinase domain-like protein (p-MLKL), and microtubule-associated protein-1 light chain-3B (LC3B) have pivotal functions in apoptosis, necroptosis, and autophagy, respectively. In vitro studies have shown that interaction of these proteins are complex and their roles in cancer can be influenced by many factors. However, these findings are not adequately assessed in human tissues. Here, we determined CC3, p-MLKL, and LC3B expression in colorectal cancers (CRCs), and assessed their associations with clinicopathological parameters, and with KRAS and p53 status. We immunohistochemically assessed 113 CRC specimens for levels of CC3, p-MLKL, LC3B, and p53. KRAS gene status was analyzed using the Scorpion- amplification refractory mutation system. High levels of CC3 (CC3 To the best of our knowledge, this is the first study to examine the combination of CC3/LC3B and p-MLKL expression in clinical CRC samples and to correlate these expression data with clinicopathological parameters and EGFR and p53 status. Our results suggest that necroptosis is a rare process in CRC, apoptosis and autophagy are upregulated in aggressive CRCs, and p53 mutation may lead to the upregulation of autophagy.

Identifiants

pubmed: 31097354
pii: S0344-0338(19)30115-3
doi: 10.1016/j.prp.2019.04.017
pii:
doi:

Substances chimiques

KRAS protein, human 0
Tumor Suppressor Protein p53 0
EGFR protein, human EC 2.7.10.1
ErbB Receptors EC 2.7.10.1
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

152425

Informations de copyright

Copyright © 2019 Elsevier GmbH. All rights reserved.

Auteurs

Fuminori Sakanashi (F)

Laboratory of Pathology, Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma, Kobe, Hyogo 654-0142, Japan; Department of Diagnostic Pathology, Fukuoka Sanno Hospital, 3-6-45 Momochihama, Sawara, Fukuoka 814-0001, Japan. Electronic address: sakanashi@kouhoukai.or.jp.

Michiko Shintani (M)

Department of Medical Technology, Kobe Tokiwa University, 2-6-2 Ohtani, Nagata, Kobe, Hyogo 653-0838, Japan.

Masazumi Tsuneyoshi (M)

Department of Diagnostic Pathology, Fukuoka Sanno Hospital, 3-6-45 Momochihama, Sawara, Fukuoka 814-0001, Japan.

Hiroyuki Ohsaki (H)

Laboratory of Pathology, Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma, Kobe, Hyogo 654-0142, Japan.

Shingo Kamoshida (S)

Laboratory of Pathology, Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma, Kobe, Hyogo 654-0142, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH